Conferences - Results from #40

ASTRO 2021: Prognostic and Predictive Performance of Routine Clinicopathologic Variables in 10,535 Men Enrolled on Randomized Phase III Trials in Localized Prostate Cancer November 1, 2021

ASTRO 2021: Impact of High Dose Radiotherapy (HEAT) in Localized Prostate Cancer: An Individual Patient Data Meta-Analysis of 15 Randomized Trials November 1, 2021

ASTRO 2021: A Phase I Trial of Neoadjuvant Stereotactic Body Radiotherapy (SBRT) Prior to Radical Prostatectomy in Locally Advanced Prostate Cancer November 1, 2021

ASTRO 2021: Performance of a Genomic Classifier Within a Phase 3 Randomized Trial of Dose Escalated Salvage Radiotherapy After Radical Prostatectomy November 1, 2021

ASTRO 2021: Emerging Role of Theranostic Imaging Agents for Patients with Biochemical Failure After Radical Prostatectomy Being Considered for Salvage External Beam Radiation November 1, 2021

ASTRO 2021: Prognostic Significance of the Risk of Non-Localized Disease on PSMA/PET: Comparative Performance of a Novel, PSMA/PET-Derived Risk Stratification Tool for High-Risk Prostate Cancer in a Large, Multi-Institutional Cohort November 1, 2021

ASTRO 2021: Short and Sweet: Optimizing Hypofractionated Therapy November 1, 2021

ASTRO 2021: Rectal Spacing: Current Evidence and Procedure Overview November 1, 2021

ASTRO 2021: Intermediate Risk Prostate Cancer: Best of Worlds for Choices, Worst of Worlds for Deciding, November 1, 2021

ASTRO 2021: Prostate Cancer: Better Living Through Biomarkers November 1, 2021

ASTRO 2021: Validation of a 22-Gene Genomic Classifier in the NRG Oncology/RTOG 9202, 9413, and 9902 Phase III Randomized Trials: A Biopsy-Based Individual Patient Meta-Analysis in High Risk Prostate Cancer November 1, 2021

ASTRO 2021: Surgery for Very High Risk to Oligometastatic Prostate Cancer November 1, 2021

ASTRO 2021: The Present and Future of Proton Beam Therapy November 1, 2021

ASTRO 2021: A Prospective Trial of Aggressive Therapy Consisting of Neoadjuvant Chemotherapy and Androgen Deprivation Followed by Prostatectomy and Adjuvant Radiation in High/Very High Risk Prostate Cancer October 30, 2021

ASTRO 2021: The Relationship Between Androgen Deprivation Therapy Duration and External Beam Radiotherapy with or without a Brachytherapy Boost in High-Risk Prostate Cancer October 30, 2021

ASTRO 2021: Advances in Prostate Brachytherapy October 30, 2021

ASTRO 2021: Elective Nodal Ultra Hypofractionated Radiation for Prostate Cancer: Safety and Efficacy from Four Prospective Trials October 30, 2021

ASTRO 2021: Molecular Imaging and Targeted Radionuclide Therapy with PSMA Radiopharmaceuticals October 30, 2021

ASTRO 2021: Defining Racial Disparities Across the Prostate Cancer Disease Continuum in an Equal Access-to-Care Setting Within the Nation's Largest Healthcare Network October 30, 2021

ASTRO 2021: Local Control in Tumor-Targeted Dose Escalation for Localized Prostate Cancer October 30, 2021

Page 3 of 429

email news signup